Blogs

Imagine being able to design new therapeutics as easily as software engineers write code. Picture living cells programmed to manufacture life-saving drugs, or AI systems predicting how molecules will behave in the human body before they even enter the lab.

Drug discovery has long been an arduous and costly process, with the average new drug taking 10-15 years and an estimated $2.6 billion to bring to market, with an estimated 10%-20% of drugs that enter clinical trials achieving approval. The inefficiencies in this system have prompted a growing interest in artificial intelligence (AI) as a transformative tool.